These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7475270)

  • 1. Bax mutations in cell lines derived from hematological malignancies.
    Meijerink JP; Smetsers TF; Slöetjes AW; Linders EH; Mensink EJ
    Leukemia; 1995 Nov; 9(11):1828-32. PubMed ID: 7475270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.
    Brimmell M; Mendiola R; Mangion J; Packham G
    Oncogene; 1998 Apr; 16(14):1803-12. PubMed ID: 9583678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
    Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
    Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
    Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
    Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
    Steube KG; Jadau A; Teepe D; Drexler HG
    Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).
    Bilim VN; Kawasaki T; Takahashi K; Tomita Y
    Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER; Piché L; Lemieux G; Lemieux R
    Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of BCL2 family member MCL1 as an early response to DNA damage.
    Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW
    Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Yin XM; Oltvai ZN; Korsmeyer SJ
    Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
    Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
    Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
    Miyashita T; Krajewski S; Krajewska M; Wang HG; Lin HK; Liebermann DA; Hoffman B; Reed JC
    Oncogene; 1994 Jun; 9(6):1799-805. PubMed ID: 8183579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.
    Kobayashi T; Ruan S; Clodi K; Kliche KO; Shiku H; Andreeff M; Zhang W
    Oncogene; 1998 Mar; 16(12):1587-91. PubMed ID: 9569026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cells regulate bcl-2 and bax expression in pro-B cells.
    Gibson LF; Piktel D; Narayanan R; Nuñez G; Landreth KS
    Exp Hematol; 1996 Apr; 24(5):628-37. PubMed ID: 8605968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Mapara MY; Daniel PT; Arnold W; Dietel M; Guski H; Feller A; Royer HD; Dörken B
    J Clin Invest; 1996 Jun; 97(11):2651-9. PubMed ID: 8647960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
    Reed JC; Meister L; Tanaka S; Cuddy M; Yum S; Geyer C; Pleasure D
    Cancer Res; 1991 Dec; 51(24):6529-38. PubMed ID: 1742726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Bax-alpha precedes apoptosis in a human B lymphoma cell line: potential role of the bcl-2 gene family in surface IgM-mediated apoptosis.
    Bargou RC; Bommert K; Weinmann P; Daniel PT; Wagener C; Mapara MY; Dörken B
    Eur J Immunol; 1995 Mar; 25(3):770-5. PubMed ID: 7705407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
    Lotem J; Sachs L
    Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
    Amundson SA; Myers TG; Scudiero D; Kitada S; Reed JC; Fornace AJ
    Cancer Res; 2000 Nov; 60(21):6101-10. PubMed ID: 11085534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.